跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目9051-9075 / 12927. (共518頁) << < 358 359 360 361 362 363 364 365 366 367 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2012-02	Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy	Journal of Clinical Oncology. 2012 Feb;30(4):613.
2021-05	Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 4090.
2010-05	Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors	Journal of Clinical Oncology. 2010 May;28(15):Abstract Number e13024.
2015-03	Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients	Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586.
2002	A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer	Oncology. 2002;63(3):239-247.
2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2013-05	A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine	Vaccine. 2013 May;31(20):2471-2476.
2006-03	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 Mar;21(3):531-536.
2008-05	Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma	Journal of Clinical Oncology. 2008 May;26(15 Suppl):Abstract number 4610.
2018-05	A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers	Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556.
2011-08-17	A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan	Cancer Chemotherapy and Pharmacology. 2011 Aug 17;67(6):1281-1289.
2002-05	Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients	Cancer Chemotherapy and Pharmacology. 2002 May;49(5):425-428.
2014-07	Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer	Oncology. 2014 Jul;87(2):104-113.
2007-05	Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy	Cancer. 2007 May;109(9):1821-1828.
2006-02	A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly	Journal of Thoracic Oncology. 2006 Feb;1(2):141-145.
2008-08	A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly	Lung Cancer. 2008 Aug;61(2):214-219.
2008-01	Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy	Lung Cancer. 2008 Jan;59(1):64-68.
2009-05-20	Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 8051.
2017-09	A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients	Scientific Reports. 2017 Sep;7:Article number 11253.
2018-01	Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma	Journal of Clinical Oncology. 2018 Jan;36(3):276-282.
2009-11	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	Cancer Chemotherapy and Pharmacology. 2009 Nov;64(6):1173-1179.
2012-02	Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma	International Journal of Radiation Oncology, Biology, Physics. 2012 Feb;82(2):817-825.
2002-10	Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy	American Journal of Clinical Oncology. 2002 Oct;25(5):509-512.
2003-02	Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel	Lung Cancer. 2003 Feb;39(2):209-214.
2000	Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)	Annals of Oncology. 2000;11:522P.

顯示項目9051-9075 / 12927. (共518頁) << < 358 359 360 361 362 363 364 365 366 367 > >> 每頁顯示[10|25|50]項目